Non-small cell lung cancer metastatic: Which Medications Are Safest? (199 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
199 medications are used for Non-small cell lung cancer metastatic, with 8,017 combined adverse event reports. The most reported drugs for Non-small cell lung cancer metastatic are CARBOPLATIN and PEMETREXED.
8,017
Total Reports
199
Drugs Used
All Medications for Non-small cell lung cancer metastatic Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| CARBOPLATIN | Carboplatin | 1,629 | 12,544 | 35,869 | 14.9% |
| PEMETREXED | Pemetrexed | 1,426 | 3,876 | 10,697 | 16.5% |
| PEMBROLIZUMAB | KEYTRUDA | 1,417 | 15,543 | 35,472 | 18.6% |
| OSIMERTINIB | TAGRISSO | 1,056 | 12,456 | 5,277 | 44.9% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 870 | 8,520 | 15,094 | 25.3% |
| PACLITAXEL | PACLITAXEL PACLITAXEL | 671 | 12,030 | 31,638 | 15.6% |
| ALECTINIB | ALECENSA | 627 | 1,055 | 1,553 | 11.5% |
| BEVACIZUMAB | JOBEVNE | 519 | 17,498 | 23,114 | 22.4% |
| NIVOLUMAB | OPDIVO | 488 | 23,086 | 36,530 | 26.3% |
| CRIZOTINIB | Xalkori | 429 | 3,173 | 2,520 | 31.9% |
| ERLOTINIB | Erlotinib | 290 | 6,791 | 3,693 | 30.2% |
| AFATINIB | Gilotrif | 285 | 1,346 | 2,055 | 22.1% |
| LORLATINIB | Lorbrena | 285 | 1,542 | 1,232 | 28.0% |
| LENVATINIB | Lenvima | 275 | 4,449 | 19,975 | 13.2% |
| CISPLATIN | CISplatin | 227 | 8,387 | 17,469 | 17.7% |
| IPILIMUMAB | YERVOY | 222 | 8,043 | 17,031 | 22.0% |
| AMIVANTAMAB | Rybrevant | 213 | 116 | 445 | 15.5% |
| AMIVANTAMAB-VMJW | - | 187 | 159 | 362 | 7.9% |
| DOCETAXEL | Docetaxel | 184 | 6,068 | 13,463 | 9.3% |
| GEMCITABINE | Gemcitabine | 133 | 5,142 | 12,268 | 16.4% |